VIGL — Vigil Neuroscience Share News
0.000.00%
Last trade - 00:00- $375.71m
- $288.60m
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Hinge Health, Pitney Bowes, Venture Global
U.S. STOCKS ON THE MOVE-Snowflake, Omnicell, Hinge Health
Vigil Neuroscience surges after Sanofi to buy co in $470 million deal
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Analog Devices, Vigil Neuroscience, Ralph Lauren
Vigil Neuroscience surge after Sanofi to buy co in $470 million deal
Deals of the day-Mergers and acquisitions
Press Digest: Wall Street Journal - May 22
Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline (updated)
Sanofi to acquire Vigil Neuroscience in $470 million deal
Brief: Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million
Brief: Vigil Neuroscience Q1 EPS USD -0.49 Vs. IBES Estimate USD -0.53
U.S. STOCKS ON THE MOVE-Vince Holding, Northern Trust, OSI Systems
U.S. STOCKS ON THE MOVE-Guidewire, Air Products, First Community
Vigil Neuroscience rises on early-stage Alzheimer's drug trial data